Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren P Mason

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Current Treatment Options in Neurology|June 22, 2005
OligodendrogliomaWarren P Mason
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2022
Focal Adhesion Kinase as a Therapeutic Target for Meningiomas With Somatic Neurofibromatosis Type 2 MutationsWarren P Mason
Neuro-Oncology|July 4, 2015
Blood-brain barrier-associated efflux transporters: a significant but underappreciated obstacle to drug development in glioblastomaWarren P Mason
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 9, 2015
Bevacizumab in recurrent glioblastoma: five informative patient scenariosWarren P Mason
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 31, 2003
Anticonvulsant prophylaxis for patients with brain tumours: insights from clinical trialsWarren P Mason
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 14, 2005
Progress in clinical neurosciences: Advances in the management of low-grade gliomasWarren P Mason
Expert Opinion on Emerging Drugs|March 7, 2008
Emerging drugs for malignant gliomaWarren P Mason
Neuro-Oncology|February 15, 2015
End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastomaWarren P Mason
Current Neurology and Neuroscience Reports|April 26, 2006
Recent advances in the treatment of oligodendrogliomasMark Agulnik, Warren P Mason
Expert Review of Neurotherapeutics|February 21, 2014
Seizure management in patients with gliomasCatherine Maurice, Warren P Mason
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Current Treatment Options in Neurology|June 22, 2005
OligodendrogliomaWarren P Mason
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2022
Focal Adhesion Kinase as a Therapeutic Target for Meningiomas With Somatic Neurofibromatosis Type 2 MutationsWarren P Mason
Neuro-Oncology|July 4, 2015
Blood-brain barrier-associated efflux transporters: a significant but underappreciated obstacle to drug development in glioblastomaWarren P Mason
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 9, 2015
Bevacizumab in recurrent glioblastoma: five informative patient scenariosWarren P Mason
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 31, 2003
Anticonvulsant prophylaxis for patients with brain tumours: insights from clinical trialsWarren P Mason
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 14, 2005
Progress in clinical neurosciences: Advances in the management of low-grade gliomasWarren P Mason
Expert Opinion on Emerging Drugs|March 7, 2008
Emerging drugs for malignant gliomaWarren P Mason
Neuro-Oncology|February 15, 2015
End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastomaWarren P Mason
Current Neurology and Neuroscience Reports|April 26, 2006
Recent advances in the treatment of oligodendrogliomasMark Agulnik, Warren P Mason
Expert Review of Neurotherapeutics|February 21, 2014
Seizure management in patients with gliomasCatherine Maurice, Warren P Mason
Pageof 12